Brady Scott Moffett

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi request reprint Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030
    Pharmacotherapy 26:1687-93. 2006
  2. doi request reprint Gentamicin dosing for pediatric patients with congenital heart disease
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, 6621 Fannin Street, MC 2 2510, Houston, TX 77030, USA
    Pediatr Cardiol 31:761-5. 2010
  3. ncbi request reprint Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, TX 77030, USA
    Am J Ther 14:331-5. 2007
  4. doi request reprint Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients
    Brady Scott Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, TX 77030, USA
    Ann Pharmacother 42:1600-4. 2008
  5. doi request reprint Sodium-nitroprusside-induced cyanide toxicity in pediatric patients
    Christopher Thomas
    Texas Children s Hospital, Department of Pharmacy, 6621 Fannin Street, MC 2 2510, Houston, TX 77030, USA
    Expert Opin Drug Saf 8:599-602. 2009
  6. ncbi request reprint Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, 6621 Fannin, St MC 2 2510, Houston, TX, 77030, USA
    Pediatr Cardiol 29:744-8. 2008
  7. ncbi request reprint Future pharmacologic agents for treatment of heart failure in children
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, 6621 Fannin Street, MC 2 2510, Houston, TX 77030, USA
    Pediatr Cardiol 27:533-51. 2006
  8. pmc Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies
    B S Moffett
    Department of Pharmacy, Texas Children s Hospital, MC 2 2510, Houston, TX 77030, USA
    Qual Saf Health Care 15:240-3. 2006
  9. doi request reprint Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review
    Brady S Moffett
    Texas Children s Hospital, Department of Pharmacy, Houston, TX, USA
    Pediatr Crit Care Med 9:403-6. 2008
  10. ncbi request reprint Safety of ketorolac in neonates and infants after cardiac surgery
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, TX 77030, USA
    Paediatr Anaesth 16:424-8. 2006

Detail Information

Publications22

  1. ncbi request reprint Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030
    Pharmacotherapy 26:1687-93. 2006
    ..To evaluate dosing and pharmacokinetic parameters of intravenous continuous-infusion procainamide in neonates, and to identify dosage regimens and factors leading to therapeutic procainamide levels and minimal adverse events...
  2. doi request reprint Gentamicin dosing for pediatric patients with congenital heart disease
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, 6621 Fannin Street, MC 2 2510, Houston, TX 77030, USA
    Pediatr Cardiol 31:761-5. 2010
    ..Pediatric patients with congenital heart disease may require alterations in gentamicin dosing. Close pharmacokinetic monitoring of aminoglycoside therapy for these patients is warranted to ensure attainment of goal concentrations...
  3. ncbi request reprint Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, TX 77030, USA
    Am J Ther 14:331-5. 2007
    ..There are no data in children regarding the efficacy and safety of acetazolamide to treat hypochloremic metabolic alkalosis...
  4. doi request reprint Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients
    Brady Scott Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, TX 77030, USA
    Ann Pharmacother 42:1600-4. 2008
    ..Cyanide toxicity may occur with the use of SNP. There is a paucity of literature describing dosing parameters or physical signs and symptoms of toxicity with SNP...
  5. doi request reprint Sodium-nitroprusside-induced cyanide toxicity in pediatric patients
    Christopher Thomas
    Texas Children s Hospital, Department of Pharmacy, 6621 Fannin Street, MC 2 2510, Houston, TX 77030, USA
    Expert Opin Drug Saf 8:599-602. 2009
    ..Conclusions: Sodium nitroprusside seems to be safe when used in critically ill pediatric patients. Cyanide toxicity may occur in patients with specific risk factors. Routine monitoring of cyanide levels may not be warranted...
  6. ncbi request reprint Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, 6621 Fannin, St MC 2 2510, Houston, TX, 77030, USA
    Pediatr Cardiol 29:744-8. 2008
    ..Pharmacist consultation can result in improved dosing of medications and cost savings. The youngest patients are most at risk for inappropriate dosing...
  7. ncbi request reprint Future pharmacologic agents for treatment of heart failure in children
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, 6621 Fannin Street, MC 2 2510, Houston, TX 77030, USA
    Pediatr Cardiol 27:533-51. 2006
    ..The education and skill of the practitioner when applying these agents in pediatric heart failure is of utmost importance...
  8. pmc Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies
    B S Moffett
    Department of Pharmacy, Texas Children s Hospital, MC 2 2510, Houston, TX 77030, USA
    Qual Saf Health Care 15:240-3. 2006
    ..There are potential risks associated with the use of warfarin in children, particularly as the dosing requirements may decrease as patients get older...
  9. doi request reprint Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review
    Brady S Moffett
    Texas Children s Hospital, Department of Pharmacy, Houston, TX, USA
    Pediatr Crit Care Med 9:403-6. 2008
    ..We assessed the effects of fenoldopam on urine output and potential deleterious changes in hemodynamics or serum creatinine in children...
  10. ncbi request reprint Safety of ketorolac in neonates and infants after cardiac surgery
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, TX 77030, USA
    Paediatr Anaesth 16:424-8. 2006
    ..There is a paucity of literature documenting the safety of using ketorolac in neonates and infants after cardiac surgery...
  11. ncbi request reprint Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030, USA
    Pharmacotherapy 26:277-80. 2006
    ..Increased vigilance is always advised when administering drugs not commonly given to pediatric patients...
  12. ncbi request reprint Nesiritide therapy in a term neonate with renal disease
    Brady S Moffett
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030, USA
    Pharmacotherapy 26:281-4. 2006
    ..This case report demonstrates the successful first use of nesiritide therapy in a neonate with renal disease. Further studies are warranted to evaluate the safety and administration of this agent in the neonatal patient population...
  13. ncbi request reprint Safety and efficacy of nesiritide in pediatric heart failure
    John L Jefferies
    Division of Pediatric Cardiology, Texas Children s Hospital, Houston, Texas 77030, USA
    J Card Fail 13:541-8. 2007
    ..We hypothesized that recombinant B-type natriuretic peptide (BNP) (nesiritide) could improve urine output and neurohormonal markers of heart failure without worsening renal function in pediatric patients...
  14. ncbi request reprint An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent
    Matthew A Studer
    Lillie Frank Abercrombie Section of Pediatric Cardiology, Department of Pediatrics Cardiology, Critical Care, Baylor College of Medicine and Texas Children s Hospital, 6621 Fannin, MC 19345 C, Houston 77030, USA
    J Heart Lung Transplant 25:857-61. 2006
    ..We report the use of clopidogrel as an alternative thrombolytic agent in the presence of pump thrombus in an adolescent patient with a DeBakey VAD Child heart pump...
  15. doi request reprint Once-daily gentamicin dosing in pediatric patients without cystic fibrosis
    Erin J McDade
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030, USA
    Pharmacotherapy 30:248-53. 2010
    ..To estimate an appropriate once-daily gentamicin dose and dosing interval for non-critical care pediatric patients older than 3 months of age without cystic fibrosis...
  16. ncbi request reprint Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure
    Jack F Price
    Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Baylor College of Medicine Texas Children s Hospital, 6621 Fannin, MC 19345 C, Houston, TX 77030, USA
    J Card Fail 12:139-43. 2006
    ..The purpose of this study was to review our institutional experience with the use of outpatient parenteral inotropic therapy (PIT) for advanced chronic heart failure in children...
  17. ncbi request reprint Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report
    Brady S Moffett
    Texas Children s Hospital, Department of Pharmacy, Houston, TX, USA
    Pediatr Crit Care Med 7:600-2. 2006
    ..We describe the use of fenoldopam to increase urine output in a pediatric patient with sepsis, heart failure, oliguria, and volume overload...
  18. ncbi request reprint Ciprofloxacin-induced renal insufficiency in cystic fibrosis
    Brady S Moffett
    Department of Pharmacy, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Park 316, Baltimore, MD 21287, USA
    J Cyst Fibros 2:152-4. 2003
    ..The incidence of this adverse effect in children and young adults who have cystic fibrosis is unknown. Multiple mechanisms for ciprofloxacin-induced nephrotoxicity have been proposed...
  19. doi request reprint Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia
    John P Breinholt
    Department of Pediatric Cardiology, Texas Children s Hospital, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA
    Pediatr Cardiol 29:804-7. 2008
    ..We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant...
  20. pmc Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients
    Mousumi Moulik
    Department of Pediatrics Cardiology, University of Texas Health Sciences Center, Houston, TX, USA
    J Am Coll Cardiol 56:582-92. 2010
    ..This study sought to evaluate the outcome and prevalence of viral endomyocardial infection after cardiac transplantation...
  21. pmc Ascertainment and epidemiology of acute kidney injury varies with definition interpretation
    Michael Zappitelli
    Montreal Children s Hospital, 2300 Tupper, Room E 222, Montreal, QC H3H1P3, Canada
    Clin J Am Soc Nephrol 3:948-54. 2008
    ..Differences in defining acute kidney injury (AKI) may impact incidence ascertainment. We assessed the effects of different AKI definition interpretation methods on epidemiology ascertainment...
  22. ncbi request reprint Hemodynamic effects of rescue protocol hydrocortisone in neonates with low cardiac output syndrome after cardiac surgery
    Pertti K Suominen
    Department of Anaesthesia and Intensive Care, Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland
    Pediatr Crit Care Med 6:655-9. 2005
    ..To assess the hemodynamic effects and safety of hydrocortisone in neonates with low cardiac output syndrome requiring high levels of inotropic support and fluid resuscitation after cardiac surgery...